Fact CheckerSign in

NCT04603196Recruiting

Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

Source: ClinicalTrials.gov · Last updated 11 May 2026

Brief summary (registry, in English)

This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which is likely detrimental to MS. Clinical data (MRI, lab results, medical history, labs, and sleep studies) of MS patients will be collected and analyzed. This will be done to study correlations between MRI, clinical data, lab studies and sleep studies. There is specific interest in the type of sleep apnea associated with MS, and whether MRI or clinical metrics of MS severity correlate with presence or absence of sleep apnea.

Status (registry)
Recruiting
Study type
Observational
Enrollment
800 (estimated)
First submitted
21 Oct 2020
Start date
20 Jun 2019
Primary completion date
20 Jun 2026
Lead sponsor
Beth Israel Deaconess Medical Center
NCT number
NCT04603196

What you commit to

  • Study type: Observational
  • Planned participants: 800
  • From 20 Jun 2019 to the primary completion date, 20 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • cannot provide informed consent

Who the study is looking for

  • Written consent
  • Over age 18
  • Confirmed diagnosis of multiple sclerosis

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beth Israel Deaconess Medical Center
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.